Featured Outsourcing Editorial
-
How Is RIM Software Transforming Regulatory Compliance?
6/20/2025
Regulatory information management (RIM) software tools streamline global regulatory processes on a single cloud-based platform throughout the entire product life cycle.
-
EMA Guideline On Clinical-Stage ATMPs Comes Into Effect: On The Verge Of Convergence?
6/19/2025
The EMA’s Guideline on quality, non-clinical and clinical requirements for investigational advanced therapy medicinal products in clinical trials came into effect on July 1, 2025
-
Formulation Development Of A JAK1 Inhibitor Extended-Release Tablet
6/19/2025
This scientific article presents a summary of the formulation development strategy of a JAK1 inhibitor extended-release tablet, with a focus on experimental design, data interpretation, and formulation decision-making.
-
Exploring The Market For Closed-Loop Cell Therapy Production
6/18/2025
The second part of a discussion on closed-loop systems explores the CDMO and equipment landscape for scaling automated closed loop cell therapy manufacturing systems.
-
Closed-Loop Manufacturing Is The Cell Therapy Revolution We Need
6/18/2025
In cell therapy manufacturing, automated closed systems with integrated software controls offer numerous benefits over traditional open systems.
-
What Global Survey Says About Scant Patient Access To CAR-T Therapy
6/17/2025
The Worldwide Network for Blood and Marrow Transplantation initiated a survey to understand cost, infrastructure, and regulatory differences affecting access.
-
Scaling Up Manufacturing? Here's Why You Need A CMC Specialist
6/16/2025
CMC experts (whether in-house or outsourced) fill a vital role during the transition from small-scale production to larger operations for maintaining quality, consistency, and compliance.
-
Amgen Bets On Agility In The Age Of AI
6/13/2025
The company is speeding up process optimization with tools like predictive analytics, digital twins, and generative AI copilots.
-
Peeling Back The Layers Of Radiolabeled Peptide Production
6/12/2025
From the moment radiolabeled drugs are made, it’s a race to get them to patients. Radioactive decay is just one of many complications. Here’s one company’s approach.
-
A Look At Elsa, The FDA's New AI Digital Assistant
6/12/2025
The U.S. FDA recently launched its very own generative AI tool called Elsa. It's designed to assist FDA employees across various functions, from scientific reviewers to investigators.